Symptoms Possible symptoms of chronic obstructive pulmonary disease (COPD) include a chronic cough, mucus production, sputum, shortness of breath, chest tightness, breath sounds, lack of energy, and sleep disturbances. The symptoms often worsen with physical exertion. An acute worsening of chronic symptoms is referred to as an exacerbation. In addition, numerous systemic and extrapulmonary concomitant … Chronic Obstructive Pulmonary Disease
Products LAMAs are commercially available as powders and inhalation solutions and are administered with a specially designed inhaler or with a nebulizer (nebulizer). LAMA is the acronym for , which means long-acting antagonists at muscarinic receptors. Structure and properties LAMAs are derived from the parasympatholytic atropine, which is a natural plant constituent found in various … LAMA
Products Umeclidinium bromide is commercially available as a powder for inhalation as a monopreparation (Incruse Ellipta) and as a fixed combination with vilanterol (Anoro Ellipta, LAMA–LABA combination). It was approved in many countries in 2014. In 2017, a combination of umeclidinium bromide, fluticasone furoate, and vilanterol was released in the EU (Trelegy Ellipta), and in … Umeclidinium Bromide
Products Ipratropium bromide is commercially available as an inhalation solution, metered-dose inhaler, and nasal spray (Atrovent, Rhinovent, generics). Combination preparations with beta2-sympathomimetics are also commercially available (Dospir, Berodual N, generics). Pharmacies also produce inhalation solutions with ipratropium bromide as extemporaneous preparations. The active ingredient has been approved in many countries since 1978. Structure and properties … Ipratropium Bromide
Products The active ingredient fluticasone has been approved in many countries since 1994 and is included in numerous drugs: Powder inhalers (Arnuity Ellipta, Seretide + salmeterol, Relvar Ellipta + vilanterol, Trelegy Ellipta + vilanterol + umeclidinium bromide). Metered dose inhalers (Axotide, Seretide + salmeterol, Flutiform + formoterol). Nasal sprays (Avamys, Nasofan, Dymista + azelastine). Nasal … Fluticasone
Products Vilanterol is commercially available as a fixed combination with fluticasone furoate in powder inhaler form (Relvar Ellipta / Breo Ellipta). It was approved in the US and EU in 2013 and in many countries in 2014. The fixed combination with umeclidinium bromide (Anoro Ellipta) was also registered in many countries in 2014. In 2017, … Vilanterol
Products Parasympatholytics are commercially available, for example, in the form of tablets, capsules, solutions, as inhalation preparations, injection solutions, and eye drops. This article refers to antagonists at muscarinic acetylcholine receptors. Antagonists at nicotinic acetylcholine receptors, such as ganglion blockers, are discussed separately. Structure and properties Many parasympatholytics are structurally derived from atropine, a natural … Parasympatholytics
